Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Iterum Therapeutics PLC

ITRM
Current price
2.11 USD +0.03 USD (+1.44%)
Last closed 2.12 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 27 665 998 USD
Yield for 12 month +59.85 %
Week
Month
Year
ITRM
21.11.2021 - 28.11.2021

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: Fitzwilliam Court, Dublin, Ireland, 2

Analytics

WallStreet Target Price

1 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 214 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -49.38 %
PEG Ratio
Return On Equity TTM -172.86 %
Wall Street Target Price 1 USD
Revenue TTM
Book Value 0.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 37 000 USD
Earnings Share -2.43 USD
Diluted Eps TTM -2.43 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ITRM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 18.08.2022
Dividend Date

Stock Valuation ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 105.2207
Price Sales TTM 1349.785
Enterprise Value EBITDA -0.399
Price Book MRQ 7.9851

Financials ITRM

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ITRM

For 52 weeks

0.6 USD 2.5 USD
50 Day MA 0.97 USD
Shares Short Prior Month 48 903
200 Day MA 1.03 USD
Short Ratio 1.24
Shares Short 60 056
Short Percent 0.47 %